626-39-1 1,3,5-Tribromobenzene 98%

Healthcare industry revolves around early accurate diagnosis and cost effective efficacious treatment. Approximately USD 120 billion is spent every year upon research and development of new medicines. Pharmaceutical companies typically spend around USD 1.3 billion to develop a single molecule investing several thousands of scientific hours while encountering numerous challenges to bring innovative medicines into the market.

Our team with several decades of experience in global pharmaceutical research and development, offers services and consultation in early drug discovery, preclinical development and early translational research. We bring insight and strategic planning that help researchers make better and faster decisions. Aravali Pharma has expertise in preparing due diligence reports for validation of therapeutic targets.

We provide services and synthesis of API/intermediates, drug impurities, specialty chemicals and analytical services. Our chemist have decades of experience in synthesis, designing of drugs and analytical chemistry.